+ 1.24
+ 0.41%
+ 2.49
+ 0.83%
+ 3.11
+ 0.85%

Cantor Fitzgerald Downgrades Aurora Cannabis to Neutral, Lowers Price Target to C$7

October 27, 2020 12:13 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Cantor Fitzgerald analyst Pablo Zuanic downgrades Aurora Cannabis (TSX:ACB) from Overweight to Neutral and lowers the price target from C$18 to C$7.

Related Articles

Cantor Fitzgerald Maintains Overweight on OrganiGram Holdings, Lowers Price Target to C$3

Cantor Fitzgerald analyst Pablo Zuanic maintains OrganiGram Holdings (TSX:OGI) with a Overweight and lowers the price target from C$5.35 to C$3. read more

420 Investor: 'This Is The Most Excited I've Ever Been' In Cannabis

Alan Brochstein, author of 420 Investor and founding partner of New Cannabis Ventures, says the recent political momentum behind the cannabis legalization push in the US — and the resulting rebound in cannabis stocks since the U.S. election — has him feeling extremely optimistic about the industry's future. read more

Canadian Cannabis Stocks Are Becoming Less Desirable Investments, Data Suggests

Cannabis stocks have taken a hit since Election Day, Nov. 3. The latest Hifyre cannabis sales data out of Canada suggests some concerning trends in the market. The Numbers: Month-over-month, Canadian retail cannabis sales were up just 4% in October and down 3% in November, Hifyre estimates. read more

PreMarket Prep Stock Of The Day: GW Pharmaceuticals

Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session. read more

Canaccord Genuity Maintains Speculative Buy on AYR Strategies, Raises Price Target to C$40

Canaccord Genuity maintains AYR Strategies (CSE:AYR) with a Speculative Buy and raises the price target from C$33 to C$40. read more